QIAGEN N.V.
QGEN · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 20-F ·
Latest disclosures
-
Latest financial period: Q4 2025
Financial facts · Filed
-
Form 20-F
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form 20-F
SEC filing · Filed
-
Form 20-F
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001015820 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- QGEN on NYSE
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- Hulsterweg 82, Pl Venlo, 5912 PL
- Incorporated in
- Netherlands
- Fiscal year end
- 31 December
- Former names on EDGAR
- QIAGEN NV (to 14 Feb 2020)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields